Experience in genetic testing of hypertrophic cardiomyopathy using nanopore DNA sequencing
Aim. To investigate the application of the Oxford Nanopore Technologies’ third generation sequencing for the genetic testing of hypertrophic cardiomyopathy.Material and methods. The study involved 12 patients with hypertrophic cardiomyopathy aged 18 to 67 years (women, 9; men, 3). Using the PCR barc...
Main Authors: | R. R. Salakhov, M. V. Golubenko, E. N. Pavlukova, A. N. Kucher, N. P. Babushkina, N. R. Valiahmetov, A. V. Markov, E. O. Belyaeva, A. F. Kanev, M. S. Nazarenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2021-11-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4673 |
Similar Items
-
Application of Long-Read Nanopore Sequencing to the Search for Mutations in Hypertrophic Cardiomyopathy
by: Ramil R. Salakhov, et al.
Published: (2022-12-01) -
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
by: Bogdan-Sorin Tudurachi, et al.
Published: (2023-06-01) -
Genetic Study of Hypertrophic Cardiomyopathy in Iranian children: The Role of a De novo Variant
by: Arastoo Kaki, et al.
Published: (2023-09-01) -
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
by: Lazar Velicki, et al.
Published: (2020-12-01) -
A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy
by: Maria V. Golubenko, et al.
Published: (2024-02-01)